Mylan cuts forecasts on delays in new drugs, weak prices

August 12, 2017 10:42 pm

Mylan cuts forecasts on delays in new drugs, weak prices
Mylan NV said on Wednesday that delays in launching key new drugs and eroding prices for generics in the United States will hurt its profitability this year and in 2018, sending its shares down more than 6 percent. FILE PHOTO: EpiPen auto-injection …

Categorised in: